The pooled analysis from five studies revealed that the AFAP1‐AS1 expression was significantly associated with GC overall survival (hazard ratio (HR) = 2.49 and 95% confidence interval (95% CI): 2.02–3.08, p  <  0.001). Here, AFAP1 is linked to gastric cancer.